GSK Investigational Site

Kirchheim -Teck, Baden-Wurttemberg 73230

0 studies enrolling now · 2 studies all time

What they study most

Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis, Hypereosinophilic Syndrome

Studies at this site

• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 — Completed
• Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) — Completed